Scientists have developed a powerful new sensor that uses light to detect extremely tiny signs of cancer in the blood, raising hopes for earlier diagnosis through a simple blood test. The technology ...

Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer ...

A new CRISPR-powered light sensor can detect the faintest whispers of cancer in a single drop of blood.

Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer biomarkers in the ...

A new highly sensitive light-based sensor can detect extremely low concentrations of cancer biomarkers in the blood.

New clinical data from Caribou Biosciences underscores significant progress for its pipeline of CRISPR-based cell therapies.

Oceanic ecosystems are increasingly threatened by global warming, which causes coral bleaching, species migration and, ...

Clinical data disclosed in November 2025 to be presented at medical meeting with new supportive translational data for both programsVispa-cel ...

Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced management will participate in the following investor conferences: ...

Department of Pharmacy, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou 350212, China The First Affiliated Hospital, Fujian Medical ...